Articles tagged as: eli lilly
August 7, 2025
Marion county lawsuits allege side effects of weight loss drugs were downplayed by drug companies
A series of lawsuits have been filed in Marion County court alleging that drug manufacturer Eli Lilly downplayed the side effects of its obesity and diabetes drugs.
Read MoreJuly 31, 2025
Senators raise questions about deals between telehealth and drug companies
Lawmakers warn the arrangement Eli Lilly and Pfizer have with telehealth platforms may lead to conflicts of interest, subpar patient care, and increase in federal health care spending.
Read MoreMarch 31, 2025
Drugmakers bleed horseshoe crab for tests. Some push for a sustainable alternative
Indianapolis Zoo and Eli Lilly are part of a push to move medical industry away from using horseshoe crab blood and towards synthetic genetically engineered alternatives.
Read MoreMarch 31, 2025
Eli Lilly’s Alzheimer’s drug not recommended by top European regulator
Eli Lilly's Alzheimer's treatment is approved for use in the U.S. but the European Medicines Agency recommended against the approval of the drug on Thursday.
Read MoreMarch 3, 2025
Indiana joins states calling for the FDA to clamp down on counterfeit weight loss drugs
Over 30 state attorneys general including in Indiana, Kentucky, and Ohio have urged the Federal Food and Drug Administration to take action against "bad actors" selling counterfeit weight loss drugs.
Read MoreFebruary 27, 2025
Indy-based pharmaceutical giant Eli Lilly to invest roughly $27 billion in manufacturing
Pharmaceutical giant Eli Lilly announced Wednesday that it plans to invest roughly $27 billion in United States manufacturing — more than doubling its investment over the past five years.
Read MoreOctober 22, 2024
Nonstop flights to Europe return to Indianapolis International Airport
The Indianapolis Airport Authority announced this week that starting next May, it will offer nonstop service between Indianapolis and Dublin, Ireland.
Read MoreOctober 2, 2024
Eli Lilly announces additional $4.5 billion investment into central Indiana LEAP District
Eli Lilly announced Wednesday it will invest another $4.5 billion into a new facility at the state’s controversial LEAP District in central Indiana.
Read MoreAugust 23, 2024
Bill Gates visits IU School of Medicine to learn about Alzheimer’s research
Bill Gates visited Indiana University School of Medicine to learn about Alzheimer's research.
Read MoreNovember 8, 2023
FDA approves new version of diabetes drug Mounjaro for weight loss
Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug. The Food and Drug Administration approved Zepbound on Wednesday. The drug has been shown to help dieters lose about a quarter of their body weight, or 60 pounds. It is the latest diabetes drug approved for weight loss, joining Novo Nordisk’s Wegovy, a high-dose version of Ozempic. Short supply and high costs have limited access to both medications. The FDA approved the new drug for people considered obese or for those who are overweight and have a weight-related health condition.
Read More